These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 13927354)

  • 1. [Experimental studies on the problem of the distribution of sulfonamides using sulfamoxole and 2-(p-aminobenzenesulfonamido)-5-methoxypyrimidine].
    KUEMMERLE HP; ROTGER P; DIMPFL J
    Chemotherapia (Basel); 1963; 6():206-11. PubMed ID: 13927354
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental studies on the distribution problem of antibiotics (tetracycline derivatives) and newer sulfonamides in pathologically-changed tissues in man. II. Sulfonamides].
    KUEMMERLE HP; ROETTGER P
    Chemotherapia (Basel); 1962; 4():546-58. PubMed ID: 13927353
    [No Abstract]   [Full Text] [Related]  

  • 3. Sulfamoxole in otorhinolaryngology.
    STEVENS EL
    Eye Ear Nose Throat Mon; 1962 Jan; 41():50-1. PubMed ID: 13917057
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical performance of sulfamoxole, a new sulfonamide. Analysis of 1240 case reports.
    CRAWFORD PF; CRAWLEY KR; TUCKER HA
    J New Drugs; 1961; 1():279-83. PubMed ID: 13882073
    [No Abstract]   [Full Text] [Related]  

  • 5. Sulfamoxole in respiratory allergy associated with infection. (Preliminary report).
    GRATER WC
    Curr Ther Res Clin Exp; 1962 Feb; 4():67-9. PubMed ID: 13901228
    [No Abstract]   [Full Text] [Related]  

  • 6. Sulfamoxole (Nuprin), a new sulfonamide, in pediatric practice.
    DUGGER JA
    J New Drugs; 1961; 1():223-9. PubMed ID: 13888264
    [No Abstract]   [Full Text] [Related]  

  • 7. [PHARMACOKINETIC STUDIES ON SULFONAMIDE THERAPY IN 3-MONTH-OLD CHILDREN].
    RIND H; GLADTKE E
    Monatsschr Kinderheilkd (1902); 1964 Apr; 112():239-40. PubMed ID: 14203496
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the stability of sulfonamides].
    Büttner H; Portwich F
    Arzneimittelforschung; 1967 Jul; 17(7):809-12. PubMed ID: 5632836
    [No Abstract]   [Full Text] [Related]  

  • 9. [On calculation of the protein adsorption factor of chemotherapeutic agents for calculation of dosage].
    Funk KF; Oelszner W
    Chemotherapy; 1965-1966; 10(4):205-16. PubMed ID: 5874620
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pyrazole sulfanilamides. II. Isomers in positions 3 and 4 of 1-phenyl-5-(p-aminobenzenesulfonamido)-pyrazole and methoxysulfanilamidopyrazoles].
    ALBERTI C
    Farmaco Sci; 1961 Jul; 16():557-70. PubMed ID: 14448268
    [No Abstract]   [Full Text] [Related]  

  • 11. [Behavior of sulfanilamides in the body].
    Reimerdes E; Thumim JH
    Arzneimittelforschung; 1970 Sep; 20(9):1171-9. PubMed ID: 4922318
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro susceptibility of gramnegative urinary tract bacteria to sulfamoxole.
    PANKEY GA; COLLIN MV
    Antibiot Chemother (Northfield); 1962 Jul; 12():440-2. PubMed ID: 14483543
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma levels of trimethoprim and sulfonamide after administration of trimethoprim-sulfamethoxazole and trimethoprim-sulfamoxole.
    Gupta KC; Desai NK; Paul T; Sheth UK
    Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(12):536-7. PubMed ID: 7228448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of 3-(p-aminobenzenesulfonamido)-2-phenylpyrazole on cholesterol metabolism].
    PETROVIC BS
    Srp Arh Celok Lek; 1961 Sep; 89():959-75. PubMed ID: 14485956
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis.
    Cribb AE; Lee BL; Trepanier LA; Spielberg SP
    Adverse Drug React Toxicol Rev; 1996 Mar; 15(1):9-50. PubMed ID: 8920632
    [No Abstract]   [Full Text] [Related]  

  • 16. [SULFAMETHOXIDINE: EXPERIMENTAL AND CLINICAL EXPERIENCES WITH THE NEW CZECHOSLOVAKIAN SULFONAMIDE 2SULFANILAMIDO-5-METHOXYPYRIMIDINE].
    KRYL R; NEUBERTOVA E; BERANOVA Z
    Cas Lek Cesk; 1964 Apr; 103():366-73. PubMed ID: 14157627
    [No Abstract]   [Full Text] [Related]  

  • 17. [THERAPEUTIC ACTION OF 2-SULFANILAMIDO-5-METHOXYPYRIMIDINE ON SUBACUTE AND CHRONIC CHOLECYSTITIS].
    VALENTI G; BELLODI G
    Policlinico Prat; 1964 Aug; 71():1273-7. PubMed ID: 14192188
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical studies with 2-sulfanilamido-5-methoxypyrimidine].
    BUENGER P; KOCH G
    Arzneimittelforschung; 1961 Aug; 11():726-36. PubMed ID: 13874434
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of a new sulfonamide with prolonged action, 2-sulfonamido-5-methoxypyrimidine, in the animal organism].
    PLACKOVA Z; HAIS IM; WAGNER J
    Cesk Farm; 1962 Jul; 11():296-302. PubMed ID: 14487059
    [No Abstract]   [Full Text] [Related]  

  • 20. [Toxicological investigations of the combination sulfamoxole/trimethoprim, a new broad-spectrum chemotherapeutic (author's transl)].
    Lagler F; Kretzschmar R; Leuschner F; Foitzik E; Kiel H; Kuhne J; Neumann W
    Arzneimittelforschung; 1976; 26(42):634-43. PubMed ID: 947324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.